Outcomes of patients with COVID-19 and coronary artery disease and heart failure: findings from the Philippine CORONA study

被引:1
|
作者
Espiritu, Adrian I. [1 ,2 ]
Pilapil, John Christopher A. [3 ]
Aherrera, Jaime Alfonso M. [3 ]
Sy, Marie Charmaine C. [1 ]
Anlacan, Veeda Michelle M. [1 ]
Villanueva, Emilio Q., III [4 ,5 ]
Jamora, Roland Dominic G. [1 ,6 ]
机构
[1] Univ Philippines Manila, Philippine Gen Hosp, Coll Med, Dept Neurosci, Manila, Philippines
[2] Univ Philippines Manila, Coll Med, Dept Clin Epidemiol, Manila, Philippines
[3] Univ Philippines Manila, Philippine Gen Hosp, Coll Med, Dept Med,Div Cardiovasc Med, Manila, Philippines
[4] Univ Philippines Manila, Coll Med, Dept Pathol, Manila, Philippines
[5] Univ Philippines Manila, Philippine Gen Hosp, Manila, Philippines
[6] Inst Neurosci, St Lukes Med Ctr, Global City, Philippines
关键词
COVID-19; Coronary artery disease; Heart failure; Mortality; Respiratory failure; Intensive care unit admission; Hospital stay; INFECTION; IMPACT;
D O I
10.1186/s13104-023-06677-5
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Patients with coronavirus disease 2019 (COVID-19) and coronary artery disease (CAD) or heart failure (HF) are more likely to have poor outcomes. This study aimed to determine the characteristics and outcomes of COVID-19 patients with CAD/HF across various institutions in the Philippines. Methods We utilized the data from the Philippine CORONA Study and compared the outcomes of admitted COVID-19 patients with CAD/HF versus those without. The Student's t test, Mann-Whitney U test, binary logistic regression and multivariate regression analysis were utilized. Odds ratios (OR) and Kaplan-Meier curves were generated. Results We included a total of 512 patients with COVID-19 had CAD/HF and 10,369 were without. CAD/HF was significantly associated with COVID severity, all-cause mortality, death from cardiac causes, respiratory failure, and prolonged hospitalization. After adjusting for confounders, the presence of CAD/HF was still associated with death from a cardiac cause (OR 2.22, 95% CI 1.49-3.3, p < 0.01). Conclusions The presence of CAD or HF was significantly associated with severity of COVID disease, all-cause mortality, death from cardiac causes, respiratory failure, and prolonged hospitalization.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Gender Difference in Covid-19 Test Status and Disease Outcomes in Heart Failure Patients
    Nedeltcheva, Arlet V.
    Doukky, Rami
    CIRCULATION, 2020, 142
  • [22] Joint effect of heart failure and coronary artery disease on the risk of death during hospitalization for COVID-19
    Angeli, Fabio
    Marazzato, Jacopo
    Verdecchia, Paolo
    Balestrino, Antonella
    Bruschi, Claudio
    Ceriana, Piero
    Chiovato, Luca
    Dalla Vecchia, Laura Adelaide
    De Ponti, Roberto
    Fanfulla, Francesco
    La Rovere, Maria Teresa
    Perego, Francesca
    Scalvini, Simonetta
    Spanevello, Antonio
    Traversi, Egidio
    Visca, Dina
    Vitacca, Michele
    Bachetti, Tiziana
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 89 : 81 - 86
  • [23] Cardiovascular Risk Factors and Clinical Outcomes among Patients Hospitalized with COVID-19: Findings from the World Heart Federation COVID-19 Study
    Prabhakaran, Dorairaj
    Singh, Kavita
    Kondal, Dimple
    Raspail, Lana
    Mohan, Bishav
    Kato, Toru
    Sarrafzadegan, Nizal
    Talukder, Shamim hayder
    Akter, Shahin
    Amin, Mohammad Robed
    Goma, Fastone
    Gomez-Mesa, Juan
    Ntusi, Ntobeko
    Inofomoh, Francisca
    Deora, Surender
    Philippov, Evgenii
    Svarovskaya, Alla
    Konradi, Alexandra
    Puentes, Aurelio
    Ogah, Okechukwu S.
    Stanetic, Bojan
    Issa, Aurora
    Thienemann, Friedrich
    Juzar, Dafsah
    Zaidel, Ezequiel
    Sheikh, Sana
    Ojji, Dike
    Lam, Carolyn S. P.
    Ge, Junbo
    Banerjee, Amitava
    Newby, L. Kristin
    Ribeiro, Antonio Luiz P.
    Gidding, Samuel
    Pinto, Fausto
    Perel, Pablo
    Sliwa, Karen
    GLOBAL HEART, 2022, 17 (01)
  • [24] Characteristics and Outcomes of Patients with Heart Failure Admitted with Covid-19 in a Cohort Study from Southeast Michigan
    Raad, Mohamad
    Gorgis, Sarah
    Dabbagh, Mohammed
    Parikh, Sachin
    Cowger, Jennifer
    JOURNAL OF CARDIAC FAILURE, 2020, 26 (10) : S74 - S74
  • [25] Racial and Ethnic Differences in Treatment and Outcomes for Patients Hospitalized with COVID-19: Findings from the American Heart Association COVID-19 Cardiovascular Disease Registry
    Rodriguez, Fatima
    Solomon, Nicole
    De Lemos, James
    Das, Sandeep
    Morrow, David
    Bradley, Steven
    Elkind, Mitchell
    Williams, Joseph
    Simon, Dajuanicia
    Matsouaka, Roland
    Gupta, Divya
    Gluckman, Ty
    Abdalla, Marwah
    Albert, Michelle
    Yancy, Clyde
    Wang, Tracy
    CIRCULATION, 2020, 142 (24) : E472 - E473
  • [26] Outcomes of COVID-19 in heart failure, LVAD, and heart transplant patients in an advanced heart failure practice
    George, Susan
    Cunningham, Luke C.
    Nelson, David P.
    Horstmanshof, Douglas A.
    Long, James W.
    El Banayosy, Ahmed M.
    AMERICAN HEART JOURNAL PLUS: CARDIOLOGY RESEARCH AND PRACTICE, 2022, 24
  • [27] The Characteristics of Coronary Artery Lesions in COVID-19 Infected Patients With Coronary Artery Disease: An Optical Coherence Tomography Study
    Ji, Shan-Shan
    Zhao, Li-Xuan
    Chen, Weiqiang
    Wang, Yi-Fan
    Liu, Fang-Chun
    Li, Hai-Peng
    He, Guo-Wei
    Zhang, Jian
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 226 : 108 - 117
  • [28] Racial and Ethnic Differences in Presentation and Outcomes for Patients Hospitalized With COVID-19 Findings From the American Heart Association's COVID-19 Cardiovascular Disease Registry
    Rodriguez, Fatima
    Solomon, Nicole
    de Lemos, James A.
    Das, Sandeep R.
    Morrow, David A.
    Bradley, Steven M.
    Elkind, Mitchell S., V
    Williams, Joseph H.
    Holmes, DaJuanicia
    Matsouaka, Roland A.
    Gupta, Divya
    Gluckman, Ty J.
    Abdalla, Marwah
    Albert, Michelle A.
    Yancy, Clyde W.
    Wang, Tracy Y.
    CIRCULATION, 2021, 143 (24) : 2332 - 2342
  • [29] INTRACARDIAC HEMODYNAMICS AND HEART RATE VARIABILITY IN STABLE CORONARY ARTERY DISEASE PATIENTS WITH CONCOMITANT COVID-19
    Netiazhenko, V.
    Mostovyi, S.
    Safonova, O.
    Mikhaliev, K.
    ATHEROSCLEROSIS, 2023, 379 : S202 - S202
  • [30] Cardiovascular disease, heart failure and COVID-19
    Faconti, Luca
    Chowienczyk, Philip J.
    Shah, Ajay M.
    JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM, 2020, 21 (02)